Obesity in Indian women is a growing crisis: Nearly half over 35 are overweight
What the numbers sayAccording to the report, the problem of obesity is not limited to urban or affluent women. In fact, the National Family Health Survey-5 (2019–21) found that 33.2% of urban women and 19.7% of rural women in India are overweight or obese (defined as BMI of more than 25 kg/m2).The numbers climb sharply with age. A study of over 6.4 lakh Indian women found that nearly 49% of those aged 35-49 were overweight or obese. In the 18–30 age group, another study revealed that more than half, 52.4%, were already obese.
According to the report, the problem of obesity is not limited to urban or affluent women. ()
advertisement"The trends are very clear. Obesity is increasing and affecting younger women, including those planning pregnancies. We need urgent action, at the clinical and public health level," the paper states.From PCOS to stillbirths, how obesity affects women's healthObesity in women is linked to a wide range of health complications, some of them unique to women. These include:Irregular periods and infertilityPolycystic Ovary Syndrome (PCOS)Gestational diabetes and high blood pressure during pregnancyHigher risk of miscarriages and stillbirthsUrinary incontinence and uterine fibroidsIncreased risk of C-sections and birth complicationsDoctors say these effects begin early, from puberty, and continue through menopause. Obesity also worsens conditions like depression, metabolic syndrome, and cardiovascular disease in postmenopausal women. The consensus calls on gynaecologists and primary care physicians to routinely assess BMI, waist circumference, and lifestyle factors in women during check-ups — especially if they are planning to conceive.Why losing 5–10% body weight can make a big differenceThe study highlights that even a modest weight loss, as little as 5–10% of body weight, can improve hormonal balance, restore ovulation, reduce insulin resistance, and increase chances of natural conception or IVF success.Women with PCOS who lost weight reported:Better menstrual regularityImproved ovulationHigher live birth ratesLower miscarriage risk
The study highlights that even a modest weight loss, as little as 5–10% of body weight, can improve hormonal balance. ()
In addition, weight loss improves urinary incontinence, mobility, and mental health, enhancing overall quality of life.'By managing obesity early, ideally before conception, we can significantly improve fertility outcomes and reduce risks during pregnancy. Our aim is to help women make small, sustainable lifestyle changes, which can go a long way in protecting maternal, fetal and child health,' said lead author Dr Nanditha Palshetkar, Medical Director, Bloom IVF Lilavati hospital.What works: Diet, exercise, therapy, and when needed, medicinesThe expert panel recommends that lifestyle changes must be the first line of treatment. This includes:Reducing sugar and saturated fatsIncreasing fiber and protein intakeAt least 150 minutes of exercise per weekMindfulness, portion control, and sleep hygieneFor some women, cognitive behavioural therapy (CBT) can help address emotional eating and support weight loss.When lifestyle changes alone are not enough, doctors may consider medication for women with BMI more than 27 and a related health condition, or BMI more than 30.advertisementCurrently, Orlistat is available in India. Semaglutide (2.4 mg) has been approved by the drug regulator but is not yet available in the Indian market. These drugs have shown significant weight-loss effects in clinical trials, alongside improvements in hormone levels and fertility parameters. However, they are not recommended during pregnancy or breastfeeding.Bariatric surgery is an option, but only for someFor women with BMI more than 35 or those with serious health complications, bariatric surgery may be considered. The procedure has been linked to rapid weight loss, improved fertility, better hormone levels, and reduced risks during pregnancy. However, conception is advised only after a 12-month waiting period post-surgery.
When lifestyle changes alone are not enough, doctors may consider medication for women. ()
What should pregnant women do?Doctors warn against using weight-loss medications during pregnancy. Instead, they recommend lifestyle interventions, like diet and exercise, as the safest and most effective way to prevent complications.advertisementWeight gain during pregnancy should be monitored and tailored to BMI categories, while postpartum weight management should involve structured programs aiming for a weight loss of 0.5 kg/week."Breastfeeding should be encouraged, and anti-obesity medications may only be considered after cessation of breastfeeding. For perimenopausal and post-menopausal women, evaluating muscle mass, bone health, and screening for metabolic disorders is crucial before implementing weight management strategies,' said study co-author Dr. Piya Ballani Thakkar, an endocrinologist specialising in diabetes and metabolic disorders.The consensus also offers trimester-specific weight gain guidelines and emphasises postpartum weight management through breastfeeding support, structured diet, and exercise — once breastfeeding stops, medications can be reconsidered under medical advice.Obesity among Indian women is not just about body image, it's a serious medical issue with long-term health consequences. The ISAR-led recommendations provide a much-needed roadmap for doctors to screen, manage, and treat obesity more effectively.Tune InMust Watch
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
7 minutes ago
- The Hindu
Simpler tests could slash biosimilar costs, widen patient access
Most of the drugs that we consume are called 'small molecule drugs'. Their chemical structure is reasonably simple. Disprin, for instance, has a molecular weight of around 180 daltons. There is another breed of drugs that are very large, complex molecules. For instance, the molecular weight of insulin is around 5,800 daltons and that of the monoclonal antibody remicade, about 150,000 daltons. (One dalton is equal to one-12th the mass of a carbon-12 atom.) Small molecule drugs also tend to have fixed structures that do not change for the duration of their use. In contrast, the complex molecules, which we call biologics, are produced in biological systems and therefore during their production slight variations in the structure may arise. However, these variations may have no impact on the stability of the molecule, its efficacy or its side effects. When a company produces a small molecule drug for the first time, it seeks patent protection for that drug. That is, no competitor may make that drug for several years. It is only when the drug goes 'off patent' that competitors may make it. In the absence of competition, the originator company can price the drug very high. Once there is competition, the competitor companies produce generics, which are copies of the original drug. They don't undertake the research and development to make the drug and they may not spend as much on marketing and sales, so the costs of generics are also much lower. Most of the drugs that you and I take are generics and are priced very cheaply compared to the originator drug. A good example is Sovaldi, a drug used to treat hepatitis C: it originally cost $84,000 for a 12-week course in the US but that dropped to $1,000 once Indian generic firms started making it. Largely it is generic drugs that keep us in India alive and well. Since biologics made by a generic firm will be produced by different biological systems, they may not be identical to those made by the originator company. Thus they are called biosimilars, not generics. For many years, a debate has raged over how much proof is required for a manufacturer to prove that a given biosimilar will work as well as the original biologic drug. Therefore, whereas much simpler testing was required to show that a generic small molecule was working like the originator molecule, there are more elaborate and expensive tests for biosimilars. Major drug regulators such as those of the US, the UK, and in Europe have been working to determine how they can simplify the requirements for approving a biosimilar, in view of the availability of modern analytical techniques. For example, the UK has removed animal trials and the US has planned to replace them with more human-relevant methods (like using organoids). In India, this requirement has not yet been updated although there is a proposal to waive animal studies on a case-by-case basis. Some have also argued that India should follow the practices of the UK and the US. The same holds for the more expensive clinical trials, which in the UK are currently required only in certain cases. Biosimilars need to be made less expensively while ensuring efficacy and minimal adverse effects. The larger the number of affordable biosimilars, the more options we will have for our patients. Gayatri Saberwal is a consultant at the Tata Institute for Genetics and Society.
Time of India
3 hours ago
- Time of India
At PGI, new hope to rein in type-2 diabetes
1 2 Chandigarh: Type 2 diabetes mellitus (T2DM) may not be invincible after all. Researchers are exploring the possibility of achieving remission through a combination of medication and lifestyle changes. The study, 'DiaRem-1' – recently published in the 'Indian journal of endocrinology and metabolism' – challenges the traditional view that T2DM is a permanent condition and provides evidence that remission is a feasible goal for some patients. The DiaRem-1 trial was an open-label, randomised controlled study at a single centre in India. It involved adult patients with T2DM of less than five years duration and an HbA1c level below 8.5% All participants were medicated for three months, followed by a three-month off-treatment period to assess for remission. Remission was officially defined as maintaining an HbA1c below 6.5% without any antidiabetic medication for three months. Nearly a third of the patients achieved remission. This small but powerful trial offers a cost-effective and scalable strategy that can work in outpatient clinics across India and the world. "With early, intensive treatment and continued support, many patients may no longer need diabetes medication. That's a powerful message of hope," said Dr Rama Walia, lead investigator of the study, adding: "Physical workout for an hour daily, including brisk walk, yoga or dance, was advised in the trial. Patients were kept on home-based healthy diet." Unlike other methods that rely on intensive, impractical diets or expensive surgeries, this study focused on using modern, widely available medications along with standard dietary and physical activity advice. Doctors now understand that two major culprits drive diabetes progression: glucotoxicity (too much sugar damaging beta cells) and lipotoxicity (fat accumulation impairing insulin action). By reversing these with medication and lifestyle therapy, the pancreas gets a much-needed break and, in some cases, begins to function more normally again. SWEAT & DIET MAY KEEP PILLS AWAY Chandigarh is considered the diabetic capital of India as the prevalence of prediabetes and diabetes is the highest in the country How Test Was Conducted Participants were divided into two groups: Intervention arm: 14 patients received a combination of liraglutide, dapagliflozin, and metformin. Control arm: 15 patients received vildagliptin, glimepiride, and metformin. Definition of Remission: HbA1c <6.5% for at least 3 months without medication Key Findings Remission Rate: 9 of the 29 participants (31%) achieved remission. Four from the intervention arm and five from control arm maintained HbA1c below 6.5% without treatment Weight Loss: Both groups experienced significant weight loss, as well as reductions in fat mass and body fat percentage. Intervention group had a median weight loss of -4.9 kg and the control group -3 kg, No Special Meds: Both modern and standard drugs helped when tightly managed Hope Floats: Not a cure, but a realistic and hopeful path to freedom from drugs Any Predictors Of Success? No baseline characteristics could be identified to predict which patients would achieve remission. However, those who did achieve remission tended to have a shorter duration of diabetes and greater weight loss. What's Next? PGI team is continuing research to test how long remission lasts and whether longer treatment duration might improve outcomes further Get the latest lifestyle updates on Times of India, along with Friendship Day wishes , messages and quotes !
Time of India
5 hours ago
- Time of India
Delhi Plans State Transplant Body To Up Organ Donations
New Delhi: Health minister Pankaj Kumar Singh formally proposed the formation of a dedicated Delhi State Organ and Tissue Transplant Organisation (SOTTO) to address the growing mismatch between organ demand and availability. The proposal comes ahead of National Organ Donation Day on Aug 3, observed annually to raise awareness and encourage people to pledge their organs. Singh said the occasion underscores the urgency of building robust systems that make it easier for families to donate organs. In a letter to Union health minister JP Nadda, Singh highlighted that Delhi — home to premier tertiary hospitals and a referral hub for the northern region — urgently needed SOTTO. At present, the city lacks a state-level transplant coordination body, which experts say hinders effective organ retrieval and allocation, especially from deceased donors. You Can Also Check: Delhi AQI | Weather in Delhi | Bank Holidays in Delhi | Public Holidays in Delhi While Delhi accounted for over 4,400 transplants in 2023, only a small fraction was from deceased donors. A dedicated SOTTO is expected to improve organ registry updates, strengthen hospital coordination, and facilitate faster matching of organs with recipients. Singh said the health department, in coordination with Indian govt's Directorate General of Health Services, has already taken proactive steps to build infrastructure and deploy trained personnel. "The proposal was submitted in accordance with the Transplantation of Human Organs and Tissues Act (THOTA), and we are ready to operationalise SOTTO at a suitable location," he wrote to Nadda. Speaking to TOI, the minister said streamlining transplants through the local SOTTO would reduce preventable deaths caused by delays. "A state-level body can improve awareness, counselling, retrieval and allocation, particularly for deceased donations." The letter added that the initiative would mark a significant milestone for the organ donation movement in Delhi and build public and stakeholder trust in ethical, transparent transplantation services. Dr Satyajit Kumar, state nodal officer for the THOTA cell, said the priority was to boost deceased organ transplants. "One deceased donor can save up to eight people," he said. "Living donations are limited, so we must strengthen brain death identification, train hospital staff, simplify legal procedures and honour donor families. Public awareness campaigns and better hospital systems are key to making deceased donation a sustainable, life-saving solution. " Get the latest lifestyle updates on Times of India, along with Friendship Day wishes , messages and quotes !
